Experimental Procedures

Materials
All reagents were purchased from Sigma-Aldrich, if not otherwise indicated.
Recombinant protein production
All proteins were expressed in E.coli BL21 Gold pLysS cells (Stratagene) with N-terminal His-tags cleavable by SUMO protease (for Plk1 and Aur-A) or by TEV protease (for Bora NT ).
The proteins were purified by cobalt-affinity chromatography using TALON resin (Clontech) as an initial step. Aur-A was additionally purified by size exclusion chromatography on a Superdex75 column (GE Healthcare). The N-terminal His-tags were cleaved using His-tagged SUMO protease (Plk1 and Aur-A) and TEV protease (Bora NT ) and cobalt-affinity chromatography was used to remove the proteases and remaining uncleaved species. Bora NT and Plk1 were further purified by ion exchange chromatography using a Mono Q column (GE Healthcare) and a Resource S column (GE Healthcare), respectively.
Finally, the proteins were subjected to size exclusion chromatography using a Superdex 200 column (GE Healthcare) for Plk1 and a Superdex 75 column for Aur-A and Bora
NT
. Plk1 was stored in 20 mM MOPS buffer pH 7.4, 100 mM NaCl, 1 mM dithiothreitol (DTT), 5 mM tris(2-carboxyethyl)phosphine (TCEP).
Aur-A was stored in 20 mM HEPES pH 7.5, 200 mM NaCl, 1 mM DTT, 5 mM TCEP, 10% (v/v) glycerol.
Bora NT was stored in 20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 5 mM TCEP.
Kinase Reactions
If not otherwise indicated, equimolar amounts of Aur-A, Bora NT and Plk1 were incubated at room temperature in 20 mM HEPES pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10 mM ATP. Reactions were quenched on ice by addition of 20 mM EDTA pH 8.0. If required, pprephosphorylation of Bora NT was achieved by overnight incubation with catalytic amounts of Aur-A (kinase:substrate ratio 1:100), after which Mg-ATP was removed. All experiments were performed in duplicate.
Native MS data acquisition
Prior to analysis, the sample buffer was exchanged to 500 mM CH3CO2NH4 pH 6.8 in 7 steps of concentration and dilution at 13,000 g and 4°C using centrifugal filter units with a 10 kDa molecular weight cutoff PES membrane (Sartorius). The protein solutions (estimated individual protein concentration = 5 µM) were loaded in gold-coated borosilicate glass needles and injected into an Orbitrap
Exactive Plus EMR mass spectrometer (Thermo Fisher Scientific) using nano-electrospray ionization.
Native mass spectra were acquired in positive ion mode with the following instrument settings: capillary voltage = 1.3-1.4 kV, source fragmentation voltage = 40 eV, ion injection time = 50 ms, higher-energy collision dissociation (HCD) energy = 10 eV, Noise threshold = 4.64, N2 gas pressure in HCD cell = 3-S4 5 × 10 -10 bar, mass resolution at 200 m/z = 17,500-35,000. Ion transfer settings were manually tuned to optimize transmission of the analyte ions and kept constant for all measurements to allow relative comparisons between samples. It was ascertained that the noise level remained below 1% relative signal intensity on a scan-to-scan basis. The mass spectrometer was externally calibrated using CsI clusters.
Native MS data analysis
To identify all species present in the mass spectra, they were converted in MassLynx-compatible RAW files using Databridge (Waters) and analyzed using MassLynx v4.1 (Waters). Species, which were consistently detected throughout the experiments, are monomeric Aur-A, monomeric Bora NT , monomeric Plk1, the noncovalent Aur-A/Bora NT 1:1 complex and the noncovalent Plk1/Bora NT 1:1 complex. For the analysis of these species, the raw mass spectra were deconvoluted to zero charge state spectra using the ReSpect algorithm within Protein Deconvolution v3.0 (Thermo Fisher Scientific). The parameters used for deconvolution were as follows: mass tolerance = 0.05-0.12 Da, minimum peak significance = 1 standard deviation, noise rejection = 68-95%, number of iterations = 3, minimum adjacent charge states = 2, number of peak models = 1-2. All other parameters were either left at their default settings or manually optimized for the respective species. All deconvoluted spectra were manually compared to the raw mass spectra to ensure correct representation of all present charge states of each species.
In all cases, the molecular weights calculated with ReSpect were consistent (within 0.01%) with the theoretical molecular weights that were calculated based on the amino acid sequences of Aur-A, Bora NT and Plk1 (see Figure S1 ), considering a 79.98 Da mass difference between the differentially phosphorylated isoforms of each species. The relative abundance of the thereby identified phosphoisoforms was derived from the ReSpect output and used to calculate the average phosphorylation state as described previously. 1 The relative protein complex abundances were respectively calculated based on the intensity ratio of Bora NT -bound Aur-A phospho-isoforms to all Aur-A-containing phosphoisoforms (
AurA bound
AurA bound + AurA free
) and the intensity ratio of Bora
NT -bound Plk1 phospho-isoforms to all
Plk1-containing phospho-isoforms (
Plk1 bound
Plk1 bound + Plk1 free ).
Native IMS-MS
Samples were prepared and introduced into the mass spectrometer as described above for the native MS experiments. Analyses were performed on a Synapt G1 HDMS Q-TOF instrument (Waters) equipped with a traveling wave ion mobility cell. The instrument was operated with the settings listed below: flow (N2) = 8 ml/min, IMS gas flow (N2) = 30 ml/min, IMS wave velocity = 150 m/s, IMS wave height linearly ramped from 4 V to 15 V over the full IMS cycle. Mass spectra were calibrated using CsI clusters and collisional cross section (CCS) calculation was facilitated by calibrating the drift time distributions as described previously, 2 comparing the drift times of denatured bovine ubiquitin, equine cytochrome C, and equine myoglobin to their reported CCS in N2 .
3 The data were processed using MassLynx v4.1 in combination with DriftScope v2.4 (Waters).
Top-down proteomics data acquisition
For top-down proteomics, Bora NT was hyperphosphorylated with catalytic amounts of Aur-A and Plk1
(molar ratio 100:1:1) and subsequently denatured by buffer exchange into 0.1% (v/v) HCOOH during 6 centrifugations at 13,000 g using 5 kDa molecular weight cutoff centrifugal filter units with PES 
Top-down proteomics data analysis
Fragment ion spectra were deconvoluted with Protein Deconvolution v3.0 (Thermo Fisher Scientific)
applying the Xtract algorithm with the parameters listed below: S/N threshold = 1.1, fit factor = 40%, remainder threshold = 10%.
To map the phosphorylation sites, deconvoluted mass spectra were analyzed using an in-house developed program written in C#. In the first step, fragment ions of each acquisition were mapped on the Bora NT amino acid sequence ( Figure S1C ), assigning them to the best matching theoretical fragment, considering b-, c-, and y-type fragment ions. 4 Subsequently, the masses of experimental and matched theoretical fragment ions were compared, for each spectrum individually calibrated around 0 ppm offset, and the resulting distribution of mass deviations was used to determine the allowed mass tolerance, which was found to be +/-2 ppm. All fragment ions with mass deviations outside this window were assumed to be false positives and discarded.
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Modified sites were then individually localized for each phospho-isoform by adding an increasing number of phosphorylations to the N-or C-terminus of the Bora NT sequence. Depending on the number of phosphorylations added, different sequence stretches are covered by fragment ions, indicating at which position a new phosphorylation occurs ( Figure S8 ). Mapped phosphorylation sites were confirmed manually, assuming that a residue, which is unequivocally shown to be phosphorylated at a lower phosphorylation state, will be phosphorylated in all higher phospho-isoforms and, conversely, that a residue, which is unambiguously shown to be unmodified, cannot be modified in any lower phosphoisoform.
Chemical cross-linking and SDS-PAGE
Cross-linking reactions were conducted using bis(sulfosuccinimidyl)suberate (BS3, Thermo Fisher 
Bottom-up proteomics
Gel bands were excised and subjected to in-gel digestion according to the standard protocol. well as phosphorylation of Ser, Thr, Tyr as dynamic modifications. Furthermore, the precursor mass tolerance was set to 10 ppm and the fragment mass tolerance was set to 0.05 Da, trypsin was specified as protease and up to 2 missed cleavages were allowed. The identified peptide spectrum matches (PSMs)
were verified using the Target Decoy PSM Validator, allowing a false-discovery rate (FDR) of 1%.
Relative quantitation of phosphorylation site occupancy
For phosphorylation site mapping, a smaller in-house database containing the Aur-A, Bora NT and Plk1 sequences shown in Figure S1 was used for the Mascot search and phosphorylated residues were located by including the phosphoRS v3.1 node 6 in the Proteome Discoverer analysis workflow.
Relative quantitation of phosphorylation site occupancy was achieved by comparing the chromatographic peak areas of phosphorylated peptides and their unphosphorylated counterparts. Peak areas were determined with Xcalibur v2.2 (Thermo Fisher Scientific) or Progenesis QI for proteomics (Nonlinear Dynamics) and manually verified. The relative phosphorylation occupancy was then calculated as [peak areas of phosphorylated peptides + unphosphorylated counterparts] * 100.
Identification of cross-linked peptides
Cross-linked peptides were identified with the in-house developed software XlinkX. 7 To this end, mass spectra were deconvoluted to charge state 1 using MS2 spectrum processor v0.9 within Proteome Discoverer v1.4 (Thermo Fisher Scientific). In XlinkX, a database of cross-linked peptides was generated based on the Aur-A, Bora NT and Plk1 sequences ( Figure S1 ) and the sequences of the E.coli proteins DnaK (UniProt: P0A6Y8) and GroEL (UniProt: P0A6F5), which were identified as minor contaminants in the initial Mascot database search. The XlinkX database was generated according to the following criteria: peptide length = 3-40 amino acids, allowed missed cleavages = 3, enzyme = trypsin, linked residue = Lys, fixed modification = Cys carbamidomethylation, variable modifications = ≤2 Met oxidations and ≤2 Ser, Thr, Tyr phosphorylations. Subsequently, the deconvoluted mass spectra were searched against the generated database in enumeration mode (for noncleavable cross-linkers), allowing a precursor mass tolerance of 10 ppm and a fragment mass tolerance of 20 ppm. Cross-link validation was achieved through a target-decoy strategy as described previously, 7 searching the deconvoluted mass spectra against a database that contained 3 shuffled decoy sequences per target sequence. The cross-links were verified based on the total number of matched fragment ions (allowing 1% FDR) and the individual N scores of the linked peptides (allowing 5% FDR). 7, 8 Mapping of the cross-links on structural models S8 was performed with Pymol v1.5 (Schrödinger, LLC) and schematic visualizations of cross-links were generated with xiNET. . This leads to a staircase-like arrangement that allows to identify the most likely phosphorylation site, i.e., the residue after which fragment ions with a higher phosphorylation state were detected. Ser43 is shown in italics, because this site was unambiguously localized based on lower phospho-isoforms, whereas the plot shown here would suggest phosphorylation of Ser47 instead, since no fragment ions between Ser43 and Ser47 were identified.
However, the added information from all phospho-isoforms allows unequivocal mapping of all phosphorylation sites (Table S3 ). 12 are shown in bold type. The transition to hyperphosphorylated Bora takes place when the protein becomes 11-13× phosphorylated, as indicated by native MS ( Figure 4B ).
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The respective phospho-isoforms are surrounded by a bold black line.
Nº of phosphorylations on Bora 
